What is an allograft?
In transplantation terminology, an allograft involves a donor and a recipient who are members of the same species but are not genetically identical. The donor provides the tissue, cells, or organ; the recipient receives it. The National Cancer Institute defines allograft in this same-species, non-identical relationship. [1]
The word is broader than any single medical product. Depending on the clinical field, “allograft” can refer to donated bone, tendon, ligament, cartilage, skin, dermis, placental tissue, or other human tissues. MTF Biologics, for example, describes allografts as donated human tissues used across different procedures. [2] The exact processing, preservation, intended use, and regulatory classification vary by tissue type and jurisdiction.
Allograft vs autograft, isograft, and xenograft
The most useful way to understand “allograft” is to compare the donor source. These terms describe biological relationships, not a ranking of what is “best.” Clinical selection depends on the procedure, patient factors, tissue availability, processing, evidence, and the treating professional’s judgment.
| Type | Donor source | Recipient relationship | General concept |
|---|---|---|---|
| Autograft | The same patient | Self → self | Tissue is moved from one site of a person’s body to another. |
| Allograft | Another human donor | Same species, genetically non-identical | Donated human tissue is transplanted to another person. |
| Isograft | Genetically identical individual | Same species, genetically identical | Classically describes grafting between identical twins. |
| Xenograft | A different species | Cross-species | Biological material comes from a non-human source. |
An autograft avoids the donor-to-recipient relationship because the patient supplies their own tissue, but it can require a second surgical site. An allograft avoids harvesting that tissue from the recipient, while introducing different considerations around donor screening, tissue processing, storage, traceability, and immune compatibility. Those trade-offs are context-dependent; this page does not recommend one graft type for an individual patient.
Common types of allograft tissue
Bone allograft
Donated human bone is used in several surgical disciplines. Bone allograft formats and processing methods vary, and the term does not imply one standardized biological behavior. Dental and orthopedic uses often dominate consumer search results, but the allograft category extends beyond bone.
Skin allograft
Skin allograft refers to donated human skin used in clinical contexts determined by appropriate product and tissue-bank documentation. Skin can also be processed into different tissue products. A “skin allograft” and an “acellular dermal matrix” should therefore not be treated as automatically interchangeable terms.
Dermal allograft
A dermal allograft is derived from donated human dermal tissue. Some dermal allografts are processed to reduce or remove cellular components while retaining a collagen-rich extracellular matrix. The NCI describes acellular cadaveric dermal matrix as a human dermis-derived allograft material from which viable cells are removed while the dermal collagen matrix is preserved. [3]
Soft-tissue allografts
Tendons, ligaments, and other donated soft tissues may also be used as allografts. The relevant quality attributes depend on the tissue and intended use, so statements about one allograft format should not be generalized to another.
Dermal allograft, acellular dermal matrix, and ADM
ADM stands for Acellular Dermal Matrix. At a category level, an ADM is a dermal scaffold produced through processing intended to remove cellular components and preserve useful elements of the extracellular matrix. [3] Human-derived ADMs can therefore fall within the broader allograft concept, but “allograft” is much broader: bone, tendon, cartilage, skin, and other human tissues can also be allografts.
The extracellular matrix (ECM) is the non-cellular structural environment of tissue. In dermis it includes collagen-rich architecture and other matrix components. Decellularization refers to processing designed to remove cellular material. Different manufacturers and tissue processors use different methods, and final products may differ in thickness, strength, sterility assurance, preservation, handling, storage, and clinical evidence. A scientific review of ADMs illustrates that these materials are not a single uniform product class. [4]
Processing, donor screening, sterilization concepts, and storage
Human tissue products can pass through multiple controlled steps such as donor screening and testing, retrieval, preparation, preservation, quarantine, banking, packaging, labeling, and storage. In Canada, Health Canada’s CTO guidance describes safety requirements that can apply to processing, storage, records, distribution, importation, and investigation/reporting, depending on the tissue and regulatory classification. [5]
“Sterile,” “aseptic,” “terminally sterilized,” and specific sterility assurance levels are technical claims and should never be inferred from the word allograft alone. Likewise, storage may be frozen, refrigerated, ambient, or otherwise controlled depending on the exact product. Clinicians and organizations should use the current Instructions for Use (IFU), labeling, tissue-bank documentation, and jurisdiction-specific requirements for the specific graft being considered.
Traceability is also part of responsible tissue handling. Lot, donor, distribution, and recipient records may be subject to product-specific and regulatory requirements. The public educational pages on Allograft.ca do not replace those controlled records.
Immune considerations, safety, and limitations
Because an allograft comes from another person, immune recognition and biological compatibility are relevant concepts. Processing can alter cellular and antigenic components, but the degree and significance depend on the tissue and process. It would be inaccurate to say that all allografts have “no rejection,” “zero complications,” or identical immune behavior.
Other limitations can include variability in donor tissue, availability, processing effects, infection-control considerations, storage requirements, cost, and evidence quality. These are not reasons to label the category as safe or unsafe in the abstract. They are reasons to evaluate the exact graft, intended use, patient context, and current evidence with a qualified professional.
Regulatory considerations
Regulation of human tissue is jurisdiction-specific and can depend on manipulation, intended use, combination with other materials, and product classification. Health Canada’s CTO framework covers defined categories of human cells, tissues, and organs and sets safety requirements for activities such as processing and storage. [5] In the United States, FDA regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps) under a framework that includes 21 CFR Parts 1270 and 1271, with additional pathways applying to some products. [6]
Therefore, a generic educational statement about allografts must not be read as evidence that a particular product is authorized, approved, cleared, registered, or indicated for a specific use. Allograft.ca only presents product-specific regulatory claims when controlled source documentation is available.
Scientific glossary
- Allograft
- A graft transferred between two genetically non-identical members of the same species.
- Autograft
- A graft moved from one location to another in the same person.
- Xenograft
- A graft or biological material transferred across species.
- Isograft
- A graft between genetically identical individuals, classically identical twins.
- ADM
- Acellular Dermal Matrix; a processed dermal scaffold in which cellular components are removed or reduced.
- ECM
- Extracellular Matrix; the non-cellular structural environment surrounding cells in tissue.
- Decellularization
- Processing intended to remove cellular material from a tissue while retaining selected matrix characteristics.
- Dermal allograft
- Human donor-derived dermal tissue used as an allograft; some dermal allografts are acellular matrices.
- AlloDerm
- A specific branded human acellular dermal matrix product; it is not a synonym for the entire allograft category. See our independent AlloDerm explainer.
Frequently asked questions
What is an allograft?
An allograft is tissue, cells, or an organ transferred from one person to another genetically non-identical person of the same species.
Is an allograft human tissue?
In human medicine, tissue allografts commonly refer to donated human tissue such as bone, tendon, skin, or dermis. “Allograft” is a donor-recipient relationship term and can also be used for cells or organs.
What is the difference between an allograft and an autograft?
An autograft uses the patient’s own tissue; an allograft uses tissue from another human donor. Each approach has different procedural and biological considerations.
What is a dermal allograft?
A dermal allograft is donor-derived human dermal tissue. Some dermal allografts are processed into acellular dermal matrices.
Is an acellular dermal matrix an allograft?
A human-derived ADM can be a type of dermal allograft. Not every ADM is necessarily human-derived, and not every allograft is an ADM.
What does ADM mean?
ADM means Acellular Dermal Matrix.
What is AlloDerm?
AlloDerm is a specific branded human acellular dermal matrix product. It should not be used as a generic synonym for allograft or ADM.
References and source notes
- NCI Dictionary — allograft
- MTF Biologics — Understanding allografts
- NCI Drug Dictionary — acellular cadaveric dermal matrix
- Peer-reviewed review — Acellular dermal matrices in reconstructive and aesthetic breast surgery
- Health Canada — Safety of Human Cells, Tissues and Organs for Transplantation Regulations
- FDA — Tissue & Tissue Products
References are provided to support general educational statements. They do not establish product-specific claims for ADM Plus or any other commercial product.